Justyna Magdalena Hermanowicz et al.
Journal of enzyme inhibition and medicinal chemistry, 36(1), 535-548 (2021-02-02)
Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in men and in women. The impact of the new pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine sulphonamide (MM-129) was evaluated against human colon cancer in vitro and in zebrafish xenografts. Our results show that this